Endovascular Engineering

Raised $80M in a Series C round, announced 7 April 2026.

Latest round Series CCountry United StatesSector Other

Round

Funds commercialization of the Hēlo platform; total raised reaches $137M.

Amount: $80M
Stage: Series C
Announced: 7 April 2026
Lead: Gilde Healthcare
Other investors: Norwest, Santé Ventures, 415 Capital, S3 Ventures, Panakès Partners, M&L Healthcare Investments
Use of funds: Funds commercialization of the Hēlo platform; total raised reaches $137M.
Checked: Announced by the company
Sources: E2 raises $80M Series C for Hēlo thrombectomy system biospace.com
E2 raises $80M Series C for Hēlo thrombectomy system ventureburn.com

Develops the Hēlo thrombectomy system for pulmonary embolism

How much has Endovascular Engineering raised?

Endovascular Engineering raised $80M in a Series C round, announced on 7 April 2026.

Who invested in Endovascular Engineering?

Gilde Healthcare led. Investors include Gilde Healthcare, Norwest, Santé Ventures, 415 Capital, S3 Ventures and Panakès Partners.